Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis

Published:2015-06-30 Issue:3 Volume:16 Page:249-265
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Salnikova L E,Kolobkov D S

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201546.pdf

Reference106 articles.

1. Glimelius B . Radiotherapy in rectal cancer. Br Med Bull 2002; 64: 141–157.

2. Mansour JC, Schwarz RE . Pathologic response to preoperative therapy: does it mean what we think it means? Ann Surg Oncol 2009; 16: 1465–1479.

3. Bai X, Li S, Yu B, Su H, Jin W, Chen G et al. Sphincter-preserving surgery after preoperative radiochemotherapy for T3 low rectal cancers. Oncol Lett 2012; 3: 1336–1340.

4. McLeod HL . Cancer pharmacogenomics: early promise, but concerted effort needed. Science 2013; 339: 1563–1566.

5. Hertz DL, McLeod HL . Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity. J Hum Genet 2013; 58: 346–352.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy;Frontiers in Genetics;2024-01-15

2. Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy;2023-09-23

3. Characterization of the gene signature correlated with favorable response to chemoradiotherapy in rectal cancer: A hypothesis‐generating study;Cancer Medicine;2023-01-09

4. Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer;Investigational New Drugs;2021-11-18

5. Circulating Biomarkers for Response Prediction of Rectal Cancer to Neoadjuvant Chemoradiotherapy;Current Medicinal Chemistry;2020-07-22